Quick Search:       Advanced Search
Effects of different concentrations of cisplatin on ovarian function in C57BL/6 mice
Received:September 10, 2019  Revised:October 23, 2019  Click here to download the full text
Citation of this paper:ZHAO Wei,XING Yan-yan,LI Wen.Effects of different concentrations of cisplatin on ovarian function in C57BL/6 mice[J].Chinese Journal of Clinical Medicine,2020,27(1):106-110
Hits: 1656
Download times: 1042
Author NameAffiliationE-mail
ZHAO Wei Reproductive Medicine Center, Changzheng Hospital, Navy Medical University, Shanghai 200003, China
Department of Gynaecology and Obestetrics, Inner Mongolia General Hospital of the Armed Police, Hohhot 010040, Inner Mongolia, China 
 
XING Yan-yan Reproductive Medicine Center, Changzheng Hospital, Navy Medical University, Shanghai 200003, China  
LI Wen Reproductive Medicine Center, Changzheng Hospital, Navy Medical University, Shanghai 200003, China 642919042@qq.com 
Abstract:Objective: To study the effect of cisplatin of different concentrations on the ovarian function in C57BL/6 mice, and to explore the minimum effective concentration that can cause premature ovarian insufficiency (POI) in C57BL/6 mice, aiming to provide a safe, reliable, and convenient POI model for clinical research. Methods: Totally, 60 female C57BL/6 mice (6-8 weeks) of SPF grade were randomly divided into control group, dose 1.0 group (1 mg/kg), dose 1.5 group (1.5 mg/kg), and dose 2.0 group (2 mg/kg), different concentrations of cisplatin were administered by the traditional intraperitoneal route for 7 days in cisplatin group. Results: In 1.0 group, ovarian tissue morphology, follicle count, and serum hormone levels were slightly different from those in the control group, but without statistical significance, therefore could not be used for modeling. In 1.5 group, the ovaries of mice were damaged heavily, their weight dropped steadily, but the general state was good, the mortality rate was low, the recovery rate of estrous cycle was low, and the ovarian histomorphology, follicle count, and serum hormone levels had statistical significance changes compared with those in the control group, but the degree of change was relatively gentle, which was suitable for the establishment of POI model. In 2.0 group, the ovaries of mice were severely damaged, their body weight dropped dramatically, the general condition was poor, and there were persistent estrous intervals. The ovarian histomorphology, follicle count, and serum hormone levels were significantly different from those in the control group, but the changes were dramatic, which was not conducive to the experimental study. Conclusions: The suitable and effective concentration of cisplatin for establishing POI model in C57BL/6 mice is 1.5 mg/kg. The ovarian tissue damage of the model established by this drug regimen is relatively stable, which can well simulate the changes in hormone levels of POI patients, and the animal has a good tolerance, which is conducive to the development of treatment studies and more suitable for the evaluation of POI treatment regimen.
keywords:premature ovarian insufficiency  cisplatin  concentration  mode
HTML  View Full Text  View/Add Comment  Download reader